Company profile for GammaDelta Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GammaDelta Therapeutics aims to harness the unique properties of γδ T cells to improve patient outcomes and survival rates among patients with haematological malignancies and solid tumours. Our mission is to deliver highly effective allogeneic immunotherapies based on the unique properties of Vδ1+ T cells with potential to provide additional benefits towards patient survival in the treatment of cancers. Our proprietary iso...
GammaDelta Therapeutics aims to harness the unique properties of γδ T cells to improve patient outcomes and survival rates among patients with haematological malignancies and solid tumours. Our mission is to deliver highly effective allogeneic immunotherapies based on the unique properties of Vδ1+ T cells with potential to provide additional benefits towards patient survival in the treatment of cancers. Our proprietary isolation and expansion protocols have the ability to selectively generate Vδ1+ T cell populations suitable for clinical application.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
The WestWorks 195 Wood Lane White City Place London W12 7FQ
Telephone
Telephone
+44 (0) 208 051 6710
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Takeda buys partner GammaDelta for cancer T-cell therapies
Takeda buys partner GammaDelta for cancer T-cell therapies

28 Oct 2021

// N. Pagliarulo BIOPHARMADIVE

https://www.biopharmadive.com/news/takeda-cell-therapy-gammadelta-acquire-deal/608996/

N. Pagliarulo BIOPHARMADIVE
28 Oct 2021

https://www.businesswire.com/news/home/20210915005601/en

BUSINESSWIRE
15 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty